Developer docs
API playgroundTry for free, no card

Search company profiles

Katalyst Diagnostics

Full company profile

uuid000xwds

Namestring
Katalyst Diagnostics
Legal namestring
Katalyst Diagnostics Ltd
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Katalyst Diagnostics is a UK-based private limited company that operates as an exclusive distributor of point-of-care diagnostic solutions for the United Kingdom and Ireland markets. The company distributes three flagship analysers: HemoScreen (a 5-minute point-of-care Full Blood Count analyser from PixCell Medical using disposable cartridges), MyCare INSITE (a sub-7-minute antipsychotic drug monitoring analyser from Saladax Biomedical covering clozapine, aripiprazole, risperidone/paliperidone, quetiapine, and olanzapine), and Piccolo Xpress (a clinical chemistry analyser offering 31 specific tests and 17 chemistry panels within 12 minutes). The Cartridge-based architecture of the HemoScreen and MyCare INSITE products eliminates calibration and maintenance requirements and produces a recurring consumables revenue stream on top of equipment placement.

Katalyst was formed in 2020 as a division of Katalyst Laboratories and serves NHS trusts, mental health services, and public healthcare organisations across the UK and Ireland. Documented customers include Oxford Health NHS Foundation Trust, Norfolk and Norwich University Hospitals NHS Foundation Trust, Mersey Care NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust, Devon Partnership NHS Trust, South London and Maudsley NHS Foundation Trust, Bradford District Care NHS Foundation Trust, and North East London NHS Foundation Trust. The company is led by co-founder and CEO Andrew Wheeler and operates from London.

The business model is a sales-led, direct distribution model targeting NHS procurement and clinical departments, with revenue generated through hardware sales of diagnostic analysers and recurring consumables (disposable cartridges and test panels). Go-to-market is concentrated in industry exhibitions such as the IBMS Congress and the POCT Innovations Conference, complemented by direct engagement with healthcare procurement and NHS framework contracts. The company does not appear to develop proprietary diagnostic technology; its value proposition rests on the exclusivity of its distribution rights and the clinical performance of the underlying manufacturer products.

Short descriptiontext

Katalyst Diagnostics is the exclusive UK and Ireland distributor of point-of-care diagnostic analysers (HemoScreen, MyCare INSITE, Piccolo Xpress), supplying NHS trusts and healthcare organisations with rapid haematology, clinical chemistry, and antipsychotic drug monitoring testing solutions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
point-of-care diagnostics, haematology analysers, clinical chemistry testing, antipsychotic drug monitoring, healthcare distribution
Industry2 codes
PRIMARYHLAHAOAG
Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Point-of-Care Diagnostics
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Diagnostic Equipment Distribution
TypeHardware Sales
Description

Distribution of point-of-care diagnostic analysers (HemoScreen, MyCare INSITE, Piccolo Xpress) and associated consumables (disposable cartridges) to NHS and healthcare organizations across UK and Ireland.

katalystdiagnostics.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Katalyst Diagnostics is the exclusive UK and Ireland distributor of three point-of-care diagnostic analyzers for NHS trusts and healthcare organisations: the HemoScreen FBC analyser (full blood counts in 5 minutes), the MyCare INSITE (antipsychotic drug monitoring in under 7 minutes), and the Piccolo Xpress (clinical chemistry panels in 12 minutes), along with their proprietary disposable cartridges. The portfolio targets emergency, oncology, ambulatory, paediatric, and mental health care pathways where rapid lab-quality results support faster clinical decisions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Lab-quality results within 5 minutes for CBC testing (vs. traditional laboratory turnaround of hours to days)
+2 more records
Product overview1 text field

Katalyst Diagnostics provides a portfolio of three point-of-care diagnostic analysers: HemoScreen™ (haematology/CBC testing with results in 5 minutes), MyCare INSITE™ (antipsychotic drug monitoring with results in <7 minutes), and Piccolo Xpress® (clinical chemistry with results in 12 minutes). The company operates as a distributor, serving NHS and healthcare organisations across the UK & Ireland, and is the exclusive UK distributor for HemoScreen™ FBC Analyser.

Product and service3 records
1HemoScreen FBC Analyser
CategoryPoint-of-care haematology analyser
Description

The world's first and only true point-of-care Full Blood Count analyser offering laboratory-quality results within 5 minutes from a single finger-prick of blood; uses patented disposable cartridges preloaded with reagents, requires no maintenance or calibration, and provides CBC plus comprehensive abnormal cell flagging for NHS use in emergency, oncology, and ambulatory care.

2MyCare INSITE Antipsychotic Drug Analyser
CategoryPoint-of-care antipsychotic drug monitoring analyser
Description

The only point-of-care analyser that measures the most commonly prescribed antipsychotic drugs, including Clozapine, Risperidone/Paliperidone, Quetiapine, Olanzapine, and Total Aripiprazole, delivering results in less than 7 minutes from a drop of blood; supports mental health pathways in distinguishing treatment resistance from adherence issues.

3Piccolo Xpress Clinical Chemistry Analyser
CategoryPoint-of-care clinical chemistry analyser
Description

Point-of-care clinical chemistry analyser providing laboratory-quality results within 12 minutes with 31 specific tests and 17 complete chemistry panels, trusted for over 30 years; supports diabetes, cholesterol, kidney, liver, and other biomarker testing at the point of care for NHS and healthcare organisations.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive distribution agreement signed for Katalyst Diagnostics to distribute PixCell's HemoScreen FBC analyser across the United Kingdom and Ireland. HemoScreen is the world's first portable, plug-and-play, 5-part differential haematology analyser offering lab quality results within 5 minutes from a single finger-prick of blood. The analyser is FDA-cleared, CE-marked, and TGA-approved for point-of-care use. Katalyst Diagnostics serves as the sole UK distributor for this flagship product.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Rapid diagnostics company spanning immunoassay, molecular, and POC testing with established hospital and clinical-lab channels. Comparable buyer segment (clinical labs, hospitals) and POC cartridge-based business model.

TypeBroad incumbent
Description

UK- and Ireland-based diagnostics company with POC clinical chemistry and immunoassay platforms plus a broader lab-testing portfolio. Operates in the same geographies and competes for NHS POC business, but at much greater scale and breadth.

TypeDirect peer
Description

POC blood-gas and immunoassay analyser company serving hospitals and clinical labs worldwide. Comparable cartridge-based POC model and similar acute-care NHS buyer segment, especially for emergency and ambulatory settings.

4Abbott Point of Care
TypeBroad incumbent
Description

i-STAT POC blood analyser franchise from Abbott, widely deployed across NHS trusts. Overlaps with Katalyst's HemoScreen and Piccolo Xpress in emergency, ambulatory, and hospital POC settings, though part of a much larger diagnostics portfolio.

TypeDirect peer
Description

Clinical chemistry and haematology POC instrument manufacturer with a 30-year installed base comparable to Piccolo Xpress. Overlaps on the clinical-chemistry POC category Katalyst distributes and shares similar NHS/hospital procurement pathways.

TypeOthers
Description

Israeli developer and manufacturer of the HemoScreen POC FBC analyser distributed exclusively by Katalyst in the UK and Ireland. Included as an ecosystem partner rather than a competitor — the upstream supplier whose commercial relationship defines Katalyst's flagship product line.

TypeBroad incumbent
Description

Global diagnostics giant with POC blood gas, chemistry, and immunoassay systems (epoc, RAPIDPoint) sold into NHS hospitals. Competes on POC clinical chemistry and haematology workflows but at enterprise scale.

TypeBroad incumbent
Description

Operates cobas POC and other near-patient testing platforms sold into NHS trusts and reference labs. Overlaps with Katalyst on clinical chemistry and broader POC menu, but as one segment within a global diagnostics franchise.

TypeDirect peer
Description

Manufacturer of POC blood gas, chemistry, and haematology analysers used in hospital and critical-care settings. Directly comparable product modality (POC blood analysis with cartridge consumables) and similar clinical buyers in emergency and ambulatory care.

TypeDirect peer
Description

Wales-based diagnostics company selling point-of-care haematology, chemistry, and diabetes testing devices globally. Closest UK-headquartered POC peer with overlapping product categories (haematology, clinical chemistry) and similar B2B distribution into healthcare providers.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Katalyst Diagnostics

Point-of-Care Diagnosticskatalystdiagnostics.com

Katalyst Diagnostics is the exclusive UK and Ireland distributor of point-of-care diagnostic analysers (HemoScreen, MyCare INSITE, Piccolo Xpress), supplying NHS trusts and healthcare organisations with rapid haematology, clinical chemistry, and antipsychotic drug monitoring testing solutions.

What Katalyst Diagnostics does

Katalyst Diagnostics is a UK-based private limited company that operates as an exclusive distributor of point-of-care diagnostic solutions for the United Kingdom and Ireland markets. The company distributes three flagship analysers: HemoScreen (a 5-minute point-of-care Full Blood Count analyser from PixCell Medical using disposable cartridges), MyCare INSITE (a sub-7-minute antipsychotic drug monitoring analyser from Saladax Biomedical covering clozapine, aripiprazole, risperidone/paliperidone, quetiapine, and olanzapine), and Piccolo Xpress (a clinical chemistry analyser offering 31 specific tests and 17 chemistry panels within 12 minutes). The Cartridge-based architecture of the HemoScreen and MyCare INSITE products eliminates calibration and maintenance requirements and produces a recurring consumables revenue stream on top of equipment placement.

Katalyst was formed in 2020 as a division of Katalyst Laboratories and serves NHS trusts, mental health services, and public healthcare organisations across the UK and Ireland. Documented customers include Oxford Health NHS Foundation Trust, Norfolk and Norwich University Hospitals NHS Foundation Trust, Mersey Care NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust, Devon Partnership NHS Trust, South London and Maudsley NHS Foundation Trust, Bradford District Care NHS Foundation Trust, and North East London NHS Foundation Trust. The company is led by co-founder and CEO Andrew Wheeler and operates from London.

The business model is a sales-led, direct distribution model targeting NHS procurement and clinical departments, with revenue generated through hardware sales of diagnostic analysers and recurring consumables (disposable cartridges and test panels). Go-to-market is concentrated in industry exhibitions such as the IBMS Congress and the POCT Innovations Conference, complemented by direct engagement with healthcare procurement and NHS framework contracts. The company does not appear to develop proprietary diagnostic technology; its value proposition rests on the exclusivity of its distribution rights and the clinical performance of the underlying manufacturer products.

Katalyst Diagnostics firmographics

Firmographics
Name
Katalyst Diagnostics
Legal name
Katalyst Diagnostics Ltd
Website
https://katalystdiagnostics.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Katalyst Diagnostics is the exclusive UK and Ireland distributor of point-of-care diagnostic analysers (HemoScreen, MyCare INSITE, Piccolo Xpress), supplying NHS trusts and healthcare organisations with rapid haematology, clinical chemistry, and antipsychotic drug monitoring testing solutions.
Ownership category
akta.pro rank

Katalyst Diagnostics industry classification

Industry
Product category
Point-of-Care Diagnostics
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAHAOAG
Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Point-of-care diagnostics
  • Haematology analysers
  • Clinical chemistry testing
  • Antipsychotic drug monitoring
  • Healthcare distribution

Where Katalyst Diagnostics is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Katalyst Diagnostics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Diagnostic Equipment Distribution: Distribution of point-of-care diagnostic analysers (HemoScreen, MyCare INSITE, Piccolo Xpress) and associated consumables (disposable cartridges) to NHS and healthcare organizations across UK and Ireland.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Katalyst Diagnostics product offering

Product offering

Core offering

Katalyst Diagnostics is the exclusive UK and Ireland distributor of three point-of-care diagnostic analyzers for NHS trusts and healthcare organisations: the HemoScreen FBC analyser (full blood counts in 5 minutes), the MyCare INSITE (antipsychotic drug monitoring in under 7 minutes), and the Piccolo Xpress (clinical chemistry panels in 12 minutes), along with their proprietary disposable cartridges. The portfolio targets emergency, oncology, ambulatory, paediatric, and mental health care pathways where rapid lab-quality results support faster clinical decisions.

Product overview

Katalyst Diagnostics provides a portfolio of three point-of-care diagnostic analysers: HemoScreen™ (haematology/CBC testing with results in 5 minutes), MyCare INSITE™ (antipsychotic drug monitoring with results in <7 minutes), and Piccolo Xpress® (clinical chemistry with results in 12 minutes). The company operates as a distributor, serving NHS and healthcare organisations across the UK & Ireland, and is the exclusive UK distributor for HemoScreen™ FBC Analyser.

Differentiator

Problem solved

Functional benefit

Products and services

  • HemoScreen FBC Analyser The world's first and only true point-of-care Full Blood Count analyser offering laboratory-quality results within 5 minutes from a single finger-prick of blood; uses patented disposable cartridges preloaded with reagents, requires no maintenance or calibration, and provides CBC plus comprehensive abnormal cell flagging for NHS use in emergency, oncology, and ambulatory care.
  • MyCare INSITE Antipsychotic Drug Analyser The only point-of-care analyser that measures the most commonly prescribed antipsychotic drugs, including Clozapine, Risperidone/Paliperidone, Quetiapine, Olanzapine, and Total Aripiprazole, delivering results in less than 7 minutes from a drop of blood; supports mental health pathways in distinguishing treatment resistance from adherence issues.
  • Piccolo Xpress Clinical Chemistry Analyser Point-of-care clinical chemistry analyser providing laboratory-quality results within 12 minutes with 31 specific tests and 17 complete chemistry panels, trusted for over 30 years; supports diabetes, cholesterol, kidney, liver, and other biomarker testing at the point of care for NHS and healthcare organisations.

Quantifiable outcome

  • Lab-quality results within 5 minutes for CBC testing (vs. traditional laboratory turnaround of hours to days)
  • +2 more outcomes

Companies that use Katalyst Diagnostics

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles1 record

Katalyst Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Katalyst Diagnostics partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • PixCell MedicalflagshipChannel Partner/ Reseller/ DistributorExclusive distribution agreement signed for Katalyst Diagnostics to distribute PixCell's HemoScreen FBC analyser across the United Kingdom and Ireland. HemoScreen is the world's first portable, plug-and-play, 5-part differential haematology analyser offering lab quality results within 5 minutes from a single finger-prick of blood. The analyser is FDA-cleared, CE-marked, and TGA-approved for point-of-care use. Katalyst Diagnostics serves as the sole UK distributor for this flagship product.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Katalyst Diagnostics competitors and assessment

Company assessment

Broad incumbents

  • QuidelOrtho: Rapid diagnostics company spanning immunoassay, molecular, and POC testing with established hospital and clinical-lab channels. Comparable buyer segment (clinical labs, hospitals) and POC cartridge-based business model.
  • Randox: UK- and Ireland-based diagnostics company with POC clinical chemistry and immunoassay platforms plus a broader lab-testing portfolio. Operates in the same geographies and competes for NHS POC business, but at much greater scale and breadth.
  • Abbott Point of Care: i-STAT POC blood analyser franchise from Abbott, widely deployed across NHS trusts. Overlaps with Katalyst's HemoScreen and Piccolo Xpress in emergency, ambulatory, and hospital POC settings, though part of a much larger diagnostics portfolio.
  • Siemens Healthineers: Global diagnostics giant with POC blood gas, chemistry, and immunoassay systems (epoc, RAPIDPoint) sold into NHS hospitals. Competes on POC clinical chemistry and haematology workflows but at enterprise scale.
  • Roche Diagnostics: Operates cobas POC and other near-patient testing platforms sold into NHS trusts and reference labs. Overlaps with Katalyst on clinical chemistry and broader POC menu, but as one segment within a global diagnostics franchise.

Direct peers

  • Radiometer: POC blood-gas and immunoassay analyser company serving hospitals and clinical labs worldwide. Comparable cartridge-based POC model and similar acute-care NHS buyer segment, especially for emergency and ambulatory settings.
  • HORIBA Medical: Clinical chemistry and haematology POC instrument manufacturer with a 30-year installed base comparable to Piccolo Xpress. Overlaps on the clinical-chemistry POC category Katalyst distributes and shares similar NHS/hospital procurement pathways.
  • Nova Biomedical: Manufacturer of POC blood gas, chemistry, and haematology analysers used in hospital and critical-care settings. Directly comparable product modality (POC blood analysis with cartridge consumables) and similar clinical buyers in emergency and ambulatory care.
  • EKF Diagnostics Holdings: Wales-based diagnostics company selling point-of-care haematology, chemistry, and diabetes testing devices globally. Closest UK-headquartered POC peer with overlapping product categories (haematology, clinical chemistry) and similar B2B distribution into healthcare providers.

Others

  • PixCell Medical: Israeli developer and manufacturer of the HemoScreen POC FBC analyser distributed exclusively by Katalyst in the UK and Ireland. Included as an ecosystem partner rather than a competitor — the upstream supplier whose commercial relationship defines Katalyst's flagship product line.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Katalyst Diagnostics social profiles

Digital presence

Katalyst Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Katalyst Diagnostics leadership team

Management profile

Number of profiles

Profiles1 record

Katalyst Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Katalyst Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Katalyst Diagnostics

What does Katalyst Diagnostics do?

Katalyst Diagnostics is the exclusive UK and Ireland distributor of three point-of-care diagnostic analyzers for NHS trusts and healthcare organisations: the HemoScreen FBC analyser (full blood counts in 5 minutes), the MyCare INSITE (antipsychotic drug monitoring in under 7 minutes), and the Piccolo Xpress (clinical chemistry panels in 12 minutes), along with their proprietary disposable cartridges. The portfolio targets emergency, oncology, ambulatory, paediatric, and mental health care pathways where rapid lab-quality results support faster clinical decisions.

Is Katalyst Diagnostics a public or private company?

Katalyst Diagnostics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Katalyst Diagnostics founded?

Katalyst Diagnostics was founded in -1. It employs 1 to 10 people.

Where is Katalyst Diagnostics based?

Katalyst Diagnostics is headquartered in London, United Kingdom, in the Europe region.

How does Katalyst Diagnostics make money?

One revenue line is on record: diagnostic Equipment Distribution.

Who are Katalyst Diagnostics's main competitors?

Broad incumbents on record are QuidelOrtho, Randox, Abbott Point of Care, Siemens Healthineers and Roche Diagnostics. Direct peers are Radiometer, HORIBA Medical, Nova Biomedical and EKF Diagnostics Holdings. PixCell Medical is listed as an others.

Does Katalyst Diagnostics have an API?

No public API is recorded for Katalyst Diagnostics.

What industry is Katalyst Diagnostics in?

Katalyst Diagnostics's product category is Point-of-Care Diagnostics. Its primary akta.pro industry code is HLAHAOAG, Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels), with a secondary code of HLAGAEAI, Sample Logistics, Biorepository & IVD Kit Management (Trial Support). Its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
KatalystdiagnosticsPress release: Katalyst Diagnostics becomes sole UK distributor for HemoScreen™ FBC Analyser – Katalyst DiagnosticsKatalyst Diagnostics became sole UK distributor for PixCell Medical's HemoScreen FBC analyzer, covering UK and Ireland. The device is the only FDA-cleared, CE-marked, TGA-approved 5-part CBC analyzer for point-of-care use. The partnership aims to improve access to rapid CBC testing in healthcare settings.WaterlandpeCruinn Boosts UK Presence with Katalyst AcquisitionCruinn Diagnostics acquired UK-based Katalyst Diagnostics, a point-of-care diagnostics business serving NHS and clinical customers. The deal adds over 100 employees and revenues above €50 million, with Cruinn targeting €150 million in revenue over the coming years.Think BusinessCruinn Diagnostics acquires UK firm KatalystCruinn Diagnostics acquired UK-based Katalyst Diagnostics, forming a €50m-plus group with over 100 employees. The deal adds Katalyst's NHS customer relationships and point-of-care diagnostics portfolio, and Cruinn aims to grow revenues to €150m through further acquisitions.Empresas de Capital Riesgo en EspaCruinn acquires Katalyst Diagnostics to enter UK market and accelerate growth strategyCruinn Diagnostics acquired UK-based Katalyst Diagnostics, a point-of-care diagnostics business serving NHS and clinical customers. The deal adds established NHS relationships and a complementary portfolio, with combined revenues above €50 million and over 100 employees. Cruinn plans to grow the group to €150 million in revenue over the coming years.PR NewswireKatalyst Diagnostics Becomes Sole Distributor of PixCell Medical's HemoScreen™ in the UK and IrelandPixCell Medical signed an exclusive distribution agreement with Katalyst Diagnostics to distribute its HemoScreen hematology analyzer in the UK and Ireland. The FDA-cleared, CE-marked, and TGA-approved device delivers lab-accurate CBC results in five minutes from a single finger-prick. The partnership aims to improve access to point-of-care testing in healthcare settings.